Humira was the leading medicine in the United States based on sales in 2022, generating 18.6 billion U.S. dollars in revenue. The branded drug – used to treat, for example, arthritis – has topped revenue rankings for a number of years and generated around six billion U.S. dollars more than second ranked Keytruda.
AbbVie in healthy position thanks to sales of top products
Spending on Humira in the United States more than doubled between 2014 and 2018. The biopharmaceutical company responsible for the production of the drug, AbbVie, generated global revenues of around 58 billion U.S. dollars in 2022. Humira, Imbruvica, and Skyrizi were AbbVie’s top three products based on sales in that year, combining for more than half of the company’s total revenue – Humira’s worldwide revenue alone accounted for more than a third.
How much money is spent on medicines in the United States?
In the United States, total nominal spending on medicines exceeded 600 billion U.S. dollars in 2022, with sales of branded drugs accounting for around 84 percent of the market. Drugs can be categorized in several ways, but a common method is to group them by what they are used to treat. In the United States, cancer, diabetes, and immunology are among the leading therapeutic categories based on sales.
Leading 10 prescription drugs based on U.S. sales in 2022
(in billion U.S. dollars)
Drug (Company)
Sales in billion U.S. dollars
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Exclusive Premium Statistic
To access all Premium Statistics, you need a paid Statista Account
* Combined sales of BMS and Pfizer.
** Comirnaty includes direct sales and alliance revenues related to sales of the Pfizer-BioNTech COVID-19 vaccine.
*** Combined sales of AbbVie and Johnson & Johnson.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Statista. (May 1, 2023). Leading 10 prescription drugs based on U.S. sales in 2022 (in billion U.S. dollars) [Graph]. In Statista. Retrieved July 03, 2024, from https://www.statista.com/statistics/258010/top-branded-drugs-based-on-retail-sales-in-the-us/
Statista. "Leading 10 prescription drugs based on U.S. sales in 2022 (in billion U.S. dollars)." Chart. May 1, 2023. Statista. Accessed July 03, 2024. https://www.statista.com/statistics/258010/top-branded-drugs-based-on-retail-sales-in-the-us/
Statista. (2023). Leading 10 prescription drugs based on U.S. sales in 2022 (in billion U.S. dollars). Statista. Statista Inc.. Accessed: July 03, 2024. https://www.statista.com/statistics/258010/top-branded-drugs-based-on-retail-sales-in-the-us/
Statista. "Leading 10 Prescription Drugs Based on U.S. Sales in 2022 (in Billion U.S. Dollars)." Statista, Statista Inc., 1 May 2023, https://www.statista.com/statistics/258010/top-branded-drugs-based-on-retail-sales-in-the-us/
Statista, Leading 10 prescription drugs based on U.S. sales in 2022 (in billion U.S. dollars) Statista, https://www.statista.com/statistics/258010/top-branded-drugs-based-on-retail-sales-in-the-us/ (last visited July 03, 2024)
Leading 10 prescription drugs based on U.S. sales in 2022 (in billion U.S. dollars) [Graph], Statista, May 1, 2023. [Online]. Available: https://www.statista.com/statistics/258010/top-branded-drugs-based-on-retail-sales-in-the-us/